Jove
Visualize
Contact Us
JoVE
x logofacebook logolinkedin logoyoutube logo
ABOUT JoVE
OverviewLeadershipBlogJoVE Help Center
AUTHORS
Publishing ProcessEditorial BoardScope & PoliciesPeer ReviewFAQSubmit
LIBRARIANS
TestimonialsSubscriptionsAccessResourcesLibrary Advisory BoardFAQ
RESEARCH
JoVE JournalMethods CollectionsJoVE Encyclopedia of ExperimentsArchive
EDUCATION
JoVE CoreJoVE BusinessJoVE Science EducationJoVE Lab ManualFaculty Resource CenterFaculty Site
Terms & Conditions of Use
Privacy Policy
Policies

Filters

Matteo Bassetti

Showing results (231-240 of 740) with videos related to

Pageof 74
Sort By:
Therapeutics and Clinical Risk Management|September 14, 2016
Safety of long-term use of linezolid: results of an open-label studyJose A Vazquez, Anthony C Arnold, Robert N Swanson, et al.
Infectious Diseases and Therapy|December 24, 2025
The Future of Antibiotics and Artificial Intelligence: Some Thoughts from Discovery to BedsideDaniele Roberto Giacobbe, Alessandra Agnese Grossi, Matteo Bassetti, et al.
Seminars in Respiratory and Critical Care Medicine|February 1, 2024
Antibiotic Strategies for Severe Community-Acquired PneumoniaMatteo Bassetti, Daniele R Giacobbe, Laura Magnasco, et al.
European Journal of Clinical Investigation|January 22, 2026
Antifungal treatment strategies in intensive care unit patientsClaudia Bartalucci, Laura Mezzogori, Riccardo Schiavoni, et al.
Current Opinion in Investigational Drugs (London, England : 2000)|September 26, 2003
Gram-positive bacterial resistance: future treatment optionsMatteo Bassetti, Giovanna Melica, Antonio Di Biagio, et al.
British Journal of Clinical Pharmacology|November 11, 2018
Successful and safe long-term treatment of cerebral aspergillosis with high-dose voriconazole guided by therapeutic drug monitoringPier Giorgio Cojutti, Maria Merelli, Lorenzo Allegri, et al.
Expert Review of Anti-Infective Therapy|December 5, 2006
Candida infections in the intensive care unit: epidemiology, risk factors and therapeutic strategiesMatteo Bassetti, Elda Righi, Mario Tumbarello, et al.
Clinical Infectious Diseases : an Official Publication of the Infectious Diseases Society of America|December 5, 2014
Potential role for telavancin in bacteremic infections due to gram-positive pathogens: focus on Staphylococcus aureusG Ralph Corey, Ethan Rubinstein, Martin E Stryjewski, et al.
Human Vaccines & Immunotherapeutics|November 12, 2020
Will vaccine hesitancy compromise our efforts to face the next SARS-CoV-2 epidemic wave?Laura Sticchi, Lucia Taramasso, Antonio Di Biagio, et al.
Expert Opinion on Drug Metabolism & Toxicology|November 18, 2024
Rezafungin acetate for the treatment of candidemia and invasive candidiasis: a pharmacokinetic evaluationMatteo Bassetti, Adam Stewart, Claudia Bartalucci, et al.
Pageof 74

Showing results (231-240 of 740) with videos related to

Sort By:
Pageof 74
Therapeutics and Clinical Risk Management|September 14, 2016
Safety of long-term use of linezolid: results of an open-label studyJose A Vazquez, Anthony C Arnold, Robert N Swanson, et al.
Infectious Diseases and Therapy|December 24, 2025
The Future of Antibiotics and Artificial Intelligence: Some Thoughts from Discovery to BedsideDaniele Roberto Giacobbe, Alessandra Agnese Grossi, Matteo Bassetti, et al.
Seminars in Respiratory and Critical Care Medicine|February 1, 2024
Antibiotic Strategies for Severe Community-Acquired PneumoniaMatteo Bassetti, Daniele R Giacobbe, Laura Magnasco, et al.
European Journal of Clinical Investigation|January 22, 2026
Antifungal treatment strategies in intensive care unit patientsClaudia Bartalucci, Laura Mezzogori, Riccardo Schiavoni, et al.
Current Opinion in Investigational Drugs (London, England : 2000)|September 26, 2003
Gram-positive bacterial resistance: future treatment optionsMatteo Bassetti, Giovanna Melica, Antonio Di Biagio, et al.
British Journal of Clinical Pharmacology|November 11, 2018
Successful and safe long-term treatment of cerebral aspergillosis with high-dose voriconazole guided by therapeutic drug monitoringPier Giorgio Cojutti, Maria Merelli, Lorenzo Allegri, et al.
Expert Review of Anti-Infective Therapy|December 5, 2006
Candida infections in the intensive care unit: epidemiology, risk factors and therapeutic strategiesMatteo Bassetti, Elda Righi, Mario Tumbarello, et al.
Clinical Infectious Diseases : an Official Publication of the Infectious Diseases Society of America|December 5, 2014
Potential role for telavancin in bacteremic infections due to gram-positive pathogens: focus on Staphylococcus aureusG Ralph Corey, Ethan Rubinstein, Martin E Stryjewski, et al.
Human Vaccines & Immunotherapeutics|November 12, 2020
Will vaccine hesitancy compromise our efforts to face the next SARS-CoV-2 epidemic wave?Laura Sticchi, Lucia Taramasso, Antonio Di Biagio, et al.
Expert Opinion on Drug Metabolism & Toxicology|November 18, 2024
Rezafungin acetate for the treatment of candidemia and invasive candidiasis: a pharmacokinetic evaluationMatteo Bassetti, Adam Stewart, Claudia Bartalucci, et al.
Pageof 74